Ritalin (methylphenidate) is a prescription central nervous system stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and certain cases of narcolepsy. Methylphenidate works by increasing dopamine and norepinephrine activity in the brain, helping improve attention span, focus, and impulse control in appropriately diagnosed patients.

Ritalin is available in oral tablet formulations, including immediate-release (IR) and extended-release (ER) versions, allowing individualized dosing based on clinical need. Treatment should be part of a comprehensive management program under the supervision of a qualified healthcare professional.

Manufactured to strict pharmaceutical-grade standards, Ritalin ensures consistent potency, safety, and therapeutic reliability. It is a prescription-only medication and should be used strictly as directed by a licensed healthcare provider.

Key Features

• Oral tablet formulation (IR and ER options available)

• Contains methylphenidate hydrochloride

• CNS stimulant for ADHD and narcolepsy treatment

• Supports focus, attention, and impulse control

• Dosing individualized based on medical supervision

• Manufactured to pharmaceutical-grade standards

• Prescription-only; Schedule II controlled substance